Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Neuromodulation and Neurorehabilitation for mTBI

NCT: NCT03819608 · RECRUITING

NCT IDNCT03819608
StatusRECRUITING
Start Date2021-04-01
Completion2026-12

Brief Summary

This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing training (APT) when combined with intermittent theta burst stimulation (iTBS), a type of repetitive transcranial magnetic stimulation and (ii) determine how APT + iTBS changes the neurocognitive system of attention in individuals with persistent attention deficits related to mTBI +/- PTSD.

Frequently Asked Questions

What is Neuromodulation and Neurorehabilitation for mTBI?

Neuromodulation and Neurorehabilitation for mTBI is a clinical trial registered under NCT03819608. Current status: RECRUITING.

What is the status of NCT03819608?

The current status of NCT03819608 (Neuromodulation and Neurorehabilitation for mTBI) is: RECRUITING.

When did Neuromodulation and Neurorehabilitation for mTBI start?

Neuromodulation and Neurorehabilitation for mTBI started on 2021-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑